Optimisation of Exercise Intensity During High-Intensity Interval Training for Glucose Control in Prediabetes
1 other identifier
interventional
14
1 country
1
Brief Summary
The aim of the current study is to identify the optimal exercise intensity of the high-intensity phase during a bout of High-Intensity Interval Training (HIIT) to increase glucose clearance in a prediabetic population. The study is a within-subjects randomised crossover design with participants attending the laboratory on seven occasions over a two week period. The first visit will be to perform medical screening and to obtain informed consent. The second visit will be to collect baseline measures, select meal plans, to collect an activity tracker and to complete a ramped exercise test to establish exercise intensity thresholds. The third visit will be to fit an interstitial glucose sensor and to collect the standardised meals which will be provided to each participant. Visits four, five, and six will be the experimental trials. The seventh visit will be to remove the interstitial glucose sensor and return the activity tracker.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2021
CompletedFebruary 22, 2022
June 1, 2021
6 months
January 30, 2020
February 21, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Area Under the Curve following first Carbohydrate load measured by continuous glucose monitoring
The area under the curve will be calculated for two hours, six hours, 12 hours and 24 hours following the fist carbohydrate load, the results will be compared between conditions.
Changes between baseline and two hours, baseline and six hours, baseline and 12 hours and baseline and 24 hours, for each condition.
Area Under the Curve following second Carbohydrate load measured by continuous glucose monitoring
The area under the curve will be calculated two hours following the second carbohydrate load, the results will be compared between conditions.
Changes between baseline and two hours for each condition.
Secondary Outcomes (4)
Changes in insulin response to exercise assessed by blood sample
Between five and eight weeks (for the duration of the study).
Changes in lactate response to exercise assessed by blood sample
Between five and eight weeks (for the duration of the study).
Changes in lipid response to exercise assessed by blood sample
Between five and eight weeks (for the duration of the study).
Mean Heart Rate (HR) during the exercise trials
Between five and eight weeks (for the duration of the study).
Study Arms (3)
Control
NO INTERVENTIONParticipants will attend the laboratory and complete no exercise. The participants will remain seated for the 29 minutes of the session.
105% VO2Peak
EXPERIMENTALParticipants will complete ten intervals at a work rate which equates to 105% VO2peak with a 1:1 work rest ratio. The recovery period will involve free cycling against no resistance. The duration of the interval and recovery periods will vary between trials so that the total work done during each trial, excluding CON, will be the same, the duration of intervals will be determined by the 50% ∆ trial which will be set at 60 s for work and recovery intervals.
50% ∆ Gas Exchange Threshold
EXPERIMENTALParticipants will complete ten intervals at a work rate which equates to 50% ∆ GET with a 1:1 work rest ratio. The recovery period will involve free cycling against no resistance. The duration of the interval and recovery periods will vary between trials so that the total work done during each trial, excluding CON, will be the same, the duration of intervals will be determined by the 50% ∆ trial which will be set at 60 s for work and recovery intervals.
Interventions
Participants will complete one of two exercise conditions (50% Delta GET or 105% VO2peak).
Eligibility Criteria
You may qualify if:
- Males
- Aged 18 years and over
- Diagnosed with prediabetes within the last 12-months (HbA1c of between 42 and 47 mmol·mol-1)
- Inactive, participating in less than 30-minutes of moderate activity on three days of the week, over the previous three months
- Mental capacity to understand the study purpose and give informed consent to participate
You may not qualify if:
- Existing cardiovascular or respiratory disease, or if the individual has any symptoms or signs of cardiovascular disease:
- pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from ischaemia
- shortness of breath at rest or with mild exertion
- dizziness or syncope
- orthopnea or paroxysmal nocturnal dyspnea
- ankle edema
- palpitations or tachycardia
- intermittent claudication
- known heart murmur
- unusual fatigue or shortness of breath with usual activities
- Any musculoskeletal conditions/injuries which could be exacerbated by exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aberystwyth Universitylead
- Hywel Dda Health Boardcollaborator
Study Sites (1)
Carwyn James Building
Aberystwyth, Ceredigion, SY23 3FD, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cerin L Brain, BSc
Aberystwyth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2020
First Posted
February 5, 2020
Study Start
June 1, 2021
Primary Completion
November 25, 2021
Study Completion
December 25, 2021
Last Updated
February 22, 2022
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will only be accessed by the immediate research team. Any data made available to other researchers will be anonymised and presented as mean and standard deviation.